BBS1 Antibodies

Santa Cruz Biotechnology delivers a wide array of BBS1 monoclonal antibodies for research focused on understanding Bardet-Biedl Syndrome and its underlying mechanisms. BBS1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). BBS1, encoded by the BBS1 gene, plays a crucial role in ciliary function and is essential for the proper functioning of cellular signaling pathways. Mutations in the BBS1 gene are associated with Bardet-Biedl Syndrome, a genetic disorder characterized by obesity, retinal degeneration, and polydactyly, highlighting the importance of BBS1 in human health. Understanding the function of BBS1 is vital for developing therapeutic strategies for this syndrome and related conditions. Research utilizing BBS1 monoclonal antibodies continues to reveal new insights into cellular mechanisms and disease pathways. Investigating BBS1's role in ciliary function has opened new avenues for therapeutic development. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Bardet-Biedl Syndrome and contribute to potential therapeutic breakthroughs.